Medical Equipment

Biotechnology Instruments Market Outlook 2026–2030 Exploring New Business Opportunities

March 10, 2026March 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Biotechnology Instruments Market During The Forecast Period 2026–2030?

The biotechnology instruments market has experienced substantial expansion in recent years. This market is projected to expand from $80.9 billion in 2025 to $86.43 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.8%. Historical growth was primarily driven by factors such as restricted automation within biotechnology laboratories, reliance on manual sample handling, expanding pharmaceutical and biotech research efforts, the uptake of traditional diagnostic instruments, and a rising need for laboratory consumables.

The biotechnology instruments market is projected to show significant growth over the next few years. It is expected to expand to $111.27 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.5%. The expansion during the forecast period can be attributed to the advancement of sophisticated lab automation instruments, the integration of AI and robotics into research workflows, the broadening of genomics and proteomics studies, increased investment in pharmaceutical R&D, and the adoption of cloud-based data management solutions. Noteworthy trends for the forecast period include a growing acceptance of lab automation instruments, a rising demand for high-throughput screening and analysis, the continued expansion of proteomics and genomics research, an increasing utilization of IVD instruments in clinical diagnostics, and a heightened focus on quality control and regulatory compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19338&type=smp

Which Major Factors Are Driving The Expansion Of The Biotechnology Instruments Market?

The rising prevalence of chronic diseases is anticipated to propel the growth of the biotechnology instruments market in the future. These long-term health issues, also known as chronic conditions or chronic illnesses, typically persist for three months or longer. The widespread occurrence of chronic diseases is attributed to factors such as unhealthy lifestyle choices, an aging population, and enhanced awareness and diagnosis. Biotechnology instruments play a crucial role in improving the quality of life for patients with chronic diseases by boosting diagnostic accuracy, optimizing treatment strategies, and facilitating more effective disease management. Additionally, they aid in identifying potential drug candidates and understanding their effects on chronic diseases. For example, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, representing an 18% increase from 3,065,825 cases in 2022. Consequently, the increasing prevalence of chronic diseases is fueling the expansion of the biotechnology instruments market.

What Market Segments Are Evaluated Within The Biotechnology Instruments Market?

The biotechnology instruments market covered in this report is segmented –

1) By Product: Lab Automation Instruments, Life Science Consumables, In Vitro Diagnostic (IVD) Instruments

2) By Application: Clinical Diagnostics, Drug Discovery And Development, Proteomics And genomics, Cell Analysis, Other Applications

3) By End-user: Pharmaceutical And Biotechnology Companies, Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:

1) By Lab Automation Instruments: Robotic Liquid Handlers, Automated Plate Readers, Automated Workstations, Lab Sample Storage Systems

2) By Life Science Consumables: Reagents And Chemicals, Sample Collection And Transport Devices, Laboratory Plasticware, Culture Media And Kits

3) By In Vitro Diagnostic (IVD) Instruments: Molecular Diagnostic Instruments, Clinical Chemistry Analyzers, Hematology Analyzers, Immunoassay Analyzers

What Industry Trends Are Redefining The Biotechnology Instruments Market?

Major companies within the biotechnology instruments market are concentrating on creating innovative products, including single-cell multi-omics products, to advance personalized medicine strategies and further genomics, proteomics, and metabolomics research. Single-cell multi-omics products are sophisticated technologies that analyze various types of biological information from individual cells, integrating data from different omics layers like genomics, transcriptomics, proteomics, and metabolomics. For example, in June 2023, Singleron Biotechnologies, a Germany-based biotechnology company, launched two cutting-edge instruments, the NEO and the Python Junior, to improve the standardization of single-cell analysis workflows. The Neo system has the capacity to process up to half a million cells in a single run across four independent channels, offering high throughput and flexibility in managing diverse applications concurrently. The Python Junior instrument is specifically engineered to dissociate solid tissues into high-quality single-cell suspensions, employing a combination of mechanical treatment and enzymatic digestion to enhance the dissociation process’s efficiency.

Who Are The Top Market Participants Influencing The Biotechnology Instruments Market?

Major companies operating in the biotechnology instruments market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Merck KGaA, Quest Diagnostics Inc., Avantor Inc., Agilent Technologies, Illumina Inc., Sartorius AG, Mettler Toledo, Perkin Elmer Inc., Shimadzu Corporation, Bruker Corporation, Zeiss Group, QIAGEN N.V., Novanta Inc., Cynosure LLC, Bio-Rad Laboratories Inc, Ori Biotech Limited, Hudson Robotics

Read the full biotechnology instruments market report here:

https://www.thebusinessresearchcompany.com/report/biotechnology-instruments-global-market-report

Which Region Currently Holds The Largest Share Of The Biotechnology Instruments Market?

North America was the largest region in the biotechnology instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biotechnology Instruments Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19338&type=smp

Browse Through More Reports Similar to the Global Biotechnology Instruments Market 2026, By The Business Research Company

Biotechnology Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/biotechnology-reagents-global-market-report

Animal Biotechnology Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-biotechnology-global-market-report

White Biotechnology Market Report 2026

https://www.thebusinessresearchcompany.com/report/white-biotechnology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795